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Abstract
Within the last decade, numerous new challenges have appeared in the UNHS arena,
such as (i) the need to validate the automated OAE/ABR screeners; (ii) the need to qualify
the responses from the automated devices; (iii) the need to obtain additional information
(i.e., hearing threshold) for the subject under assessment, in a short period of time; (iv)
and the need to integrate numerous measurements in a single portable automated device.
To respond to these clinical demands, several new methodologies have been introduced
to the UNHS clinical practice. In this context, the aim of this chapter is to provide infor‐
mation on these new technological trends.
Keywords: Automated otoacoustic emissions (AOAE), automated auditory brainstem re‐
sponse (AABR), wideband reflectance, middle ear power analysis, neonatal hearing
screening, auditory state steady response, hearing threshold
1. Introduction
Otoacoustic emissions (OAEs) or cochlear echoes is a term coined by David Kemp in 1978 [1],
describing the transient responses from the inner ear, upon its stimulation by an acoustic click
stimulus. During the last 20 years, OAE protocols have been used in many areas of audiology
and hearing science [2]. The most significant contribution of OAEs is in the area of universal
neonatal hearing screening (UNHS).
While the main objective of neonatal hearing screening (NHS) is the identification of infants
with a hearing deficit (≥30 dB HL), the objectives of a UNHS program have a broader vision.
Two important phases are considered: (i) the identification of infants with mild and moderate
hearing deficits and (ii) an intervention in terms of hearing improvement (hearing aids and
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cochlear implants) and neural rehabilitation, aiming at the restoration of hearing and the
normalization of the quality of life of the young patient.
Within the last decade, numerous new challenges have appeared in the UNHS arena, such as
(i) the need to validate the automated OAE/ABR screeners; (ii) the need to qualify the responses
from the automated devices; (iii) the need to obtain additional information (i.e., hearing
threshold) for the subject under assessment, in a short period of time; and (iv) the need to
integrate numerous measurements in a single portable automated device. To respond to these
clinical demands, several new methodologies have been introduced to the UNHS clinical
practice. In this context, the aim of this chapter is to provide information on these new
technological trends.
2. Automated auditory brainstem responses
In the early 2002, the first fourth-generation OAE devices appeared in the market and offered
the possibility to integrate information from different testing protocols such as automated OAE
(AOAE) and automated ABR (AABR) responses. The combined screening protocols (AOAE +
AABR) targeted the identification of auditory neuropathy, most prevalent in the neonatal
intensive care (NICU) environment.
With the introduction of the AABR protocols in the NHS programs, several issues became
evident, and among those questions related to screening times and screening costs. The latter
is outside the objectives of this paper and will not be addressed. A previous study of our group,
in the context of the regional NHS project CHEAP in Emilia-Romagna, Italy [3], provided
evidence suggesting that in terms of time-requirements, portable ABR (Audioscreener, Viasys;
Accuscreen, GN-Otometrics; Algo 3i, Natus) and OAE devices were converging to the same
time values. Data from the above study suggested that (i) the average time for AOAE responses
is less than 10 s in a cooperative subject and less that 120 s (2 min) in non-cooperative subjects
and (ii) the average AABR test times were less than 120 s, while longer times (600 s per ear)
were required for uncooperative subjects. The placement of the AABR electrodes might be a
complicated process, especially when highly skin impedances (caused by excessive lipid
layers) are encountered. In these cases, the AABR algorithms tend to oversample in order to
derive a coherent signal, and as a result, the testing times are significantly prolonged.
A combined two-stage approach (i.e., AOAE + AABR) eliminates the risk of not identifying
infants with auditory neuropathy and assures that the screening sensitivity is high. Contrary
to this hypothesis, data from a large-scale American study by White et al. [4] suggest that this
is not always the case. From 86,634 screened infants, using a two-stage OAE/A-ABR protocol,
23% would have passed the AABR.
Another interesting development in the ABR/AABR area is in the area of the evoking stimulus.
Traditionally, ABR and AABR protocols use click stimuli to synchronize as many neural fibers
as possible and to obtain an ABR response of large amplitude with less sweeps. Recently, chirp
stimuli have been used to optimize the ABR/AABR responses. According to Kristensen and
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Elberling [5], “Upward chirps are often designed to compensate for the cochlear traveling wave
delay which is regarded as independent of stimulation level. A chirp based on a traveling wave
model is therefore referred to as a level-independent chirp. Another compensation strategy,
for instance based on frequency-specific auditory brainstem response (ABR) latencies, results
in a chirp that changes with stimulation level and is therefore referred to as a level-dependent
chirp. One such strategy, the direct approach, results in a chirp family that is called the level-
specific chirp.” Data from studies using level-dependent chirps [6–11] are very encouraging,
reporting ABRs recorded in less time and with higher amplitude values. The latter is very
important for the statistical algorithms of the AABR devices, meaning that higher statistical
accuracy can be obtained in the chirp-evoked AABRs.
3. Middle ear reflectance and Middle Ear Power Analysis (MEPA)
Data from studies that have evaluated the performance of NHS programs in the well-baby
clinic or in the NICU [4, 12, 13] have reported that the majority of “screening refers” are due
to transmission impeding factors such as the amniotic fluid or any substance blocking the
propagation of the acoustic stimulus. Usually, these conditions are transient (i.e., they last 24–
30 h), and infants can pass the OAE test when the fluid is absorbed or when the auditory meatus
is clean.
Using a middle ear power analysis (MEPA) testing procedure, it is possible to determine
whether the middle ear conducts properly acoustic stimuli, and in this context, the OAE
screening results can be interpreted more clearly. Data from the literature [14, 15] have shown
that one of the MEPA metrics, the middle ear reflectance, is more sensitive to the distortion
product OAE (DPOAE) status than the 1-kHz tympanometry values. Power reflectance is a
measure of middle ear inefficiency. It is the ratio or percentage of power reflected from the
eardrum to the incident power as a function of frequency. Acoustic power measurements
objectively quantify middle ear function or malfunction.
Currently, there is only one manufacturer (Mimosa Acoustics) offering reflectance measure‐
ments. The company offers two devices capable of MEPA, DPOAE, and general OAE meas‐
urements: the Otostat (handheld) and the HearID (research oriented) model. These devices
(depicted in Figure 1) can measure wideband power reflectance up to 6 kHz and most
importantly without the need for a pressurized ear canal.
To interpret the clinical usefulness of the MEPA approach, Hunter et al. [15] constructed
normative regions for newborns, relating middle ear reflectance values evoked by chirp stimuli
and DPOAE amplitudes at 1.0, 1.5, 2.0, 3.0, 4.0, and 6.0 kHz. The three regions were described
as follows:
1. A retest area (where the values of reflectance are high)
2. An ambiguous area (where the values of reflectance are moderate)
3. A pass area (where the values of reflectance are low)
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These areas are depicted in Figure 2. In terms of interpretation, If the MEPA reflectance values
fall above the “pass” area, especially around 2 kHz, outer or middle ear problems may be the
cause, and a rescreening session after a few hours or a day is recommended prior to diagnostic
referral. If the outcome is still a “refer” then clinical assessment is necessary. If the MEPA
reflectance values fall within the “pass” area, especially around 2 kHz, the middle ear is more
Figure 1. The Mimosa Acoustic devices capable of recording wideband reflectance and OAEs. Data from the Mimosa
Acoustics website (http://www.mimosaacoustics.com).
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likely to be normal and associated with a DPOAE pass result. If the DPOAE result is ambiguous
or a “refer”, then middle ear issues are not suspected as a hearing deficit cause and further
clinical assessment is necessary. Table 1 summarizes all these outcomes.
Figure 2. Pass, ambiguous, and retest regions for wideband reflectance using chirp (solid regions) and sine (symbols)
stimuli. Results above this region, especially at 2 kHz, are associated with false-positive DPOAE refer results. Data
from the Mimosa Acoustics website and from Hunter et al. (2010).
Overall DPOAE result Reflectance at 2.0 kHz Interpretation
Pass In the pass area Pass—normal result
Pass Above the pass area ( i.e., in the ambiguous orretest area)
Pass—may have middle ear issues,
cochlear response normal
Refer In the pass area Refer—consistent with SNHL, requiresfollow-up
Refer Above the pass area (i.e., in the ambiguous orretest areas)
Rescreening is suggested; repeat MEPA to
determine status of the middle ear
Table 1. How to interpet distortion product OAEs and reflectance results in newborns (from http://
www.mimosaacoustics.com).
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4. Auditory Steady-State Responses (ASSR)
OAE and ABR testing procedures are evoked by electrical transient stimuli (clicks, filtered
clicks, etc.), and as a result, the responses are correlated with a few audiometric frequencies,
which correspond to the maximum spectral content of the stimulus (around 2.0 kHz). Con‐
sidering this clinical setup, there are other protocols that could be candidates for a hearing
assessment of neonates, children, and adults. Among those is the electrocochleography (EcoG),
the middle latency (ML) responses, and the most recently reported steady-state responses
(SSR). The first two approaches can be excluded because they require long times either for the
position of an intratympanic electrode or for sampling purposes. The last protocol has shown
a good potential for hearing screening since with an adequate manipulation of the stimulus
modulation frequency, one can record responses or from the auditory cortex (low modulation
frequencies around 40 Hz) or from the brainstem (frequencies around 50–120 Hz) [16–18]. The
basic SSR protocol has evolved into an automated procedure (ASSR) where multiple stimulus
frequencies are used and regression models predict hearing levels at the tested stimuli. The
ASSR protocols have been greatly optimized for lower frequency stimuli such as 500 Hz [19].
In 2002, Conne-Wesson et al. [16] suggested that it could be possible to use an SSR protocol in
a Neonatal Hearing Program, and since the SSR responses were generated by the brainstem
for modulation frequencies >40 Hz, the ASSR could substitute the AABR [20–22]. In the
referenced studies, a good agreement has been reported between the ASSR and the AABR
responses at 2.0 kHz and various significant differences at 0.5, 1.0, and 4.0 kHz. The available
data suggest that the AASR protocols should be developed further to become more independ‐
ent of various clinical factors (related to the tested subject and to the stimuli used) and should
be applied on a large population of subjects so that the results can be easily used clinically.
The important factors affecting the AABR responses (i.e., the ambient noise and the skin-
electrode impedance) interfere also with the ASSR recordings. In 2010, Vivosonic presented a
new family of devices (called amplitrodes) using a novel approach. Each scalp electrode was
connected to a small preamplifier within the electrode assembly. Amplifying the signal in situ
has many advantages, such as the suppression of the ambient noise and the elevation of the
signal-to-noise ratio (S/N). This approach results in clean AABR and ASSR traces. One of the
issues reported since its release, is that the new electrodes require very often a change of the
electrode batteries.
In the context of a neonatal screening, an ASSR screening protocol can focus on discrete
frequency points (i.e., 1.0 and 2.0 kHz or 2.0 and 4.0 kHz), which show relative immunity to
ambient noise, as shown in the neonatal data in Figures 3A and 3B. One of the problems of the
early ASSR devices (Audera by Viasys; Master by Natus) was that the mean hearing threshold
estimates were characterized by large variance. Recent data in the literature and specifically
from the Audix equipment developers (Neuronic) report significant advances both in terms
of software and hardware and a superior performance of a multiple SSR protocol to the
conventional ABR [23, 24].
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Figure 3. A) ASSR responses from a non-cooperative infant, using the AUDERA ASSR device (VIASYS). Responses at
500 Hz were not available due to noise caused by myogenic artifacts. The ASSR recording time was 14 min longer that
the AABR test, resulting as 22 min. The large size of the error bars, at 2.0 and 4 kHz, show threshold means at 60 and
55 dB HL, but the variability of the measurements makes the threshold prediction difficult to be considered. (B) ASSR
response from another well-baby infant, using the same ASSR device. The ASSR recording was also significantly lon‐
ger than the AABR response (16 vs. 7 min). The error bars around the threshold average (indicated by an “x”) are small
and the prediction can be considered practical. For example, at 1.0 kHz, the threshold level is shown at 55 dB with a
95% probability that it will be in the interval 35–65 dB HL. The latter estimates are derived from the values of the error
bars.
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Recently, a study by Ciorba et al. [25] presented data on the relationship between ABR, ASSR
estimates, and data from Conditioned Orientation Responses (COR), a technique widely
diffused in the intervention phase of many UNHS programs. The data suggested a very good
relationship between the outcomes of the ASSR and the COR techniques, with the ASSR data
being closer to the ABR estimates. Data from large-scale studies along this direction (i.e.,
comparing ASSR with other protocols) could support this hypothesis and eliminate the use of
ABR and COR in this intervention step.
5. Threshold estimation via DPOAE measurements
From the early nineties, where OAEs were accepted in the clinical practice, the relationship
between hearing threshold and OAE responses received a lot of attention [26–28]. What
previous research suggests is that in cases presenting sensorineural deficits (i.e., excluding
conductive and retrocochlear causes), there is a good agreement between the OAE respond
levels and the hearing threshold. In this context, distortion product OAE (DPOAE) protocols
can provide additional information [26, 29–31]. Input–output (or I/O functions) DPOAE
protocols provide information on the relationship between the evoking stimulus and the signal
compression of the cochlear amplifier. Data supporting this hypothesis are derived from
animal experiments (furosemide intoxication) [32] and clinical human studies from cases
presenting sensorineural deficits [29, 33–34]. When the hearing loss is increased, the slope of
the corresponding DPOAE I/O-functions decreases and reveals a loss of compression in the
cochlear amplifier. Using various setups of the DPOAE I/O stimuli, one can estimate the
cochlear compression, which is related to a specific threshold value [31, 35]. Janssen et al. [36]
used this concept to produce a relationship between DPOAE I/O amplitude values and hearing
threshold. According to their data, “The hearing threshold was found to be increasing within
the early postnatal period (average age: 3 days), predominantly at the higher frequencies, and
to be normalized in a follow-up measurement (after four weeks). However, the slope of the
DPOAE I/O-functions obtained in the first and second measurement was unchanged revealing
normal cochlear compression. Consequently, these findings were interpreted as temporary
conductive hearing losses due to the presence of amniotic fluid and/or Eustachian tube
dysfunction.” The value of cochlear compression changes when the middle ear stimulus
pathway is affected. Therefore, this procedure has the theoretical potential to discriminate
middle from inner ear deficits. Data from the literature have not validated yet this hypothesis.
The research findings from Janssen et al. [36] and Gorga et al. [35] have been commercialized
by Natus in the Cochlea-Scan device [37]. Hearing threshold can be extrapolated up to values
relative to 50 dB HL in the frequency range from 1.5 to 6 kHz. Figure 4 shows a typical hearing
threshold profile and the corresponding Cochlea-Scan-mediated estimation of hearing
threshold. At present, the Cochlea-Scan device offers a platform for a third-generation OAE
testing (TEOAEs and DPOAEs), I/O DPOAE estimation with hearing threshold extrapolation.
Further analyses [38, 39] on the efficacy of the Cochlea-Scan DPOAE algorithm, relating
hearing threshold data and Cochlea-Scan estimated thresholds from a group of adult sensor‐
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ineural cases, suggested a different scenario than the one proposed initially by Janssen et al.
[36]. In the Hatzopoulos et al. [39] study, behavioral and Cochlea-Scan data were analyzed
with logistic regression models in order to find the probability (≤0.9) of a robust DPOAE
response at 2.0, 3.0, and 4.0 kHz. The data suggested that the maximum behavioral levels where
valid DPOAEs could be detected were equal to of 32.8, 21, and 34 dB, respectively. For normal
hearing adults, the detection levels were lower. Figures 5 and 6 depict the relationship between
behavioral data (at 2.0, 3.0, and 4.0 kHz) and Cochlea-Scan estimates from the cases presenting
hearing loss. For example, in Figure 5 and for 2.0 kHz, a probability of 90% Cochlea-Scan
response detection corresponds to a threshold approximately of 15 dB HL. In this context, it
is still possible to have a detection threshold as high as 50 dB HL. The corresponding proba‐
bility falls below 30% and, as such, limits the usefulness of the Cochlea-Scan protocol
Figure 4. Cochlea-Scan data in comparison to behavioral threshold levels, from an adult subject. Top panel: Cochlea-
Scan responses and threshold estimation from the right ear; middle panel: behavioral data; bottom panel: Cochlea-Scan
responses and threshold estimation from the left ear. The Cochlea-Scan panels report the estimated threshold values
per frequency. The acronym “NA” means that at the specific frequency no threshold estimation was possible.
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Figure 5. Logistic regression model for normal hearing threshold Cochlea-Scan data at 2.0 and 3.0 kHz. The equation
relating the two variables (c = Cochlea-Scan; p = behavioral threshold) is shown at the top of each graph. The x axis
shows behavioral threshold in dB HL and the y axis the probability of a Cochlea-Scan response. For a fixed response
probability of 90%, the detectable threshold level is approximately 15 and 20 dB HL, for the data at 2.0 and 3.0 kHz.
This implies that in order to obtain a Cochlea-Scan response for a 50-dB HL hearing threshold, the probability of find‐
ing a true response drops to 40% and 10%, respectively (for 2.0 and 3.0 kHz).
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Figure 6. Logistic regression model for normal hearing threshold Cochlea-Scan data at 4.0 kHz. The equation relating
the two variables (c = Cochlea-Scan; p = behavioral threshold) is shown at the top of each graph. The x axis shows
behavioral threshold in dB HL and the y axis the probability of a Cochlea-Scan response. For a fixed response probabil‐
ity of 90%, the detectable threshold level is approximately 35 dB HL. For a 50-dB HL threshold, the probability of a
true response drops to 15%. The relationship between the behavioral and the Cochlea-Scan data at 4.0 kHz is opti‐
mized, but the sensitivity of the method drops very quickly as we move to higher thresholds 35 dB HL.
The authors at this point in time could not verify if Natus has intentions of developing further
this product. Cochlea-Scan threshold estimation could be greatly improved by introducing
changes in the device’s algorithms related to (i) the sample size, which was used to calibrate
the prototype device. Sampling a larger population can minimize the variance of the average
DPOAE amplitude per tested frequency (ii) by inserting correction factors in the algorithm,
which extrapolates DPOAE amplitudes to hearing levels. Janssen et al. [36] have used a linear
regression model to achieve this, but higher-order models (quadratic, cubic) can offer higher
precision in the threshold estimation.
6. Integration of multiple hearing assessment protocols into an automated
device
The success of the NHS screening practices challenged another area of pediatric audiology,
the area of schoolchildren screening. Data from large-scale screening programs, as in Poland,
suggested that in this area different protocols could be applied than in UNHS programs, with
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emphasis on pure tone behavioral responses, tympanometry, and ABR [40]. The OAEs were
found the less effective tool in the battery of screening tests, suffering mainly from the ambient
noise present in schools.
Recently, the fifth-generation OAE equipment appeared in the market. A number of OAE
manufacturers (Natus, Path Medical solutions) proposed handheld devices capable of testing
subjects with OAEs/AOAEs, AABR, and ASSR. A tympanometry assessment has not appeared
so far due to complications in the probe of the device (canal pressurization issues). Mimosa
Acoustics offers wide-reflectance measurements (which can substitute acoustic immittance)
and OAEs but not evoked potentials.
The proposal from Path Medical Solutions (model: Sentiero—advanced) is a device capable
not only of AOAE/AABR/ASSR protocols but also of protocols for speech Audiometry. The
device is depicted in Figure 7. Such a device can be easily implemented in both phases
(identification and intervention) of a UNHS program, and it is hoped that other manufacturers
will follow this protocol-integration trend.
Figure 7. The Sentiero Advanced device (data from the website of Path medical solutions http://www.pathme.de).
7. Conclusions
During the last 10–15 years, significant advances have been made toward the integration of
various protocols and technologies in UNHS strategies. The most important contribution is in
the area of auditory steady-state responses, which has been shown to be well correlated with
other metrics in audiology such as the AABR, ABR, OAEs, and COR. The current technological
trends call for an integration of even more protocols and algorithms in a handheld device. The
clinical robustness and response quality of these new entries is yet to be evaluated.
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8. Appendix
The reader interested in additional information than the one presented might visit the OAE
Portal (http://www.otoemissions.org) and the OAE Portal Forum.
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